Colour sensor breath test can detect lung cancer

	Tweet

Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array

A breath test can successfully pick up lung cancer with “moderate accuracy” even in the early stages, reveals research published ahead of print in Thorax.

It could revolutionise the way cancer is detected and potentially save lives, say the authors.

The test comprises a chemical colour sensor, which detects tiny changes in the unique chemical signature of the breath of people with lung cancer.

Metabolic changes in lung cancer cells cause changes in the production and processing of volatile organic compounds, which are then breathed out

The researchers used the colour sensor to test the breath of 122 people with different types of respiratory disease, and 21 healthy people.

Included in the group with respiratory illness were 49 people with small cell lung cancer at various stages of development.

The research team used the sensor results from 70% of the study participants to develop a predictive model, the accuracy of which was then tested on the remaining 30%.

The results showed that the test was able to accurately predict the presence of cancer in just under three out of four of those with lung cancer.

The results were not affected by age, gender, or stage of disease.

Other approaches to breath testing have been used, say the authors. This includes gas chromatography and mass spectrometry, which requires a great deal of expertise to use and is very expensive.

As cancer is often silent in its early stages and symptoms are often not specific, it is often difficult to pick up the disease at a stage when it could be treated effectively, say the authors.

Diagnosis is often therefore only made when the disease is advanced.

“Ultimately, this line of investigation could lead to an inexpensive, non-invasive screening or diagnostic test for lung cancer,” they conclude.

BMJ Specialty Journals

RELATED STORIES:
Study sheds light on breast cancer drug failure   Group therapy fails to improve breast cancer survival   Male breast cancer rare, but can be aggressive   10,000-plus in US die for lack of cancer screens: CDC   Physicians validate reclassification of breast cancer stages   Study Questions “Cancer Stem Cell” Hypothesis in Breast Cancer   Interval post-treatment mammogram not needed for breast cancer patients   Overweight Young Women Have Reduced Risk of Developing Breast Cancer Before Menopause   Residual fetal cells in women may provide protection against breast cancer   Study Shows Chemotherapy Improves Survival Among Older Breast Cancer Patients   Breast cancer breakthrough as scientists discover faulty gene linked to half of all cases   New approach to treating breast cancer uses existing chemo drug   Lasers Illuminate Women’s Health in inaugural open-access journal Biomedical Optics Express   Radiotherapy boost helps early breast cancer   Alcohol use may raise risk of second breast cancer   Surviving Lung Cancer; New Technique Boasts High Cure Rates, Offers Hope in Place of Surgery   Scientists unravel breast cancer risk gene mystery   Roadmap published for dynamic mapping of estrogen signaling in breast cancer   Tracking and feedback registry may reduce racial disparities in breast cancer care   Spirituality Plays Important Role in Breast Cancer Information Processing for African-American Women   Ethnic breast cancer gap tied to mammography rates   Breast cancer surgery decisions difficult for many

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]